Posted: September 12, 2007

Award-winning nanomedicine animation video

(Nanowerk News) Hybrid Medical Animation announced today that it took home two platinum best of show and two gold at this year’s Aurora Awards. This is the second consecutive year the Minneapolis-based animation studio has been given the top honor.
Three of four Auroras this year came from the “Use of Special Effects/ Animation” category. The platinum winner from this category, “Rexin-G Mechanism of Action”, was created for Epeius Biotechnologies Corporation. The animation depicts the molecular mechanisms of its revolutionary Rexin-G cancer therapy.
“Our top molecular biologists were awed by the striking realism and artful flow of the tumor-targeting and gene-delivery themes that Hybrid orchestrated,” said Epeius president, Dr. Frederick Hall.
nanomedicine video
Frames from the award-winning animation
Rexin-G is the world's first tumor-targeted nanomedicine, a targeted gene delivery system that seeks out and destroys cancers that have spread throughout the body. Rexin-G has demonstrated efficacy against a broad spectrum of tumors where chemotherapy and other treatments have failed.
“The client’s hands off approach really allowed us to innovate on the Rexin-G project,” said Jeffrey Johnson, founder and creative director for Hybrid. “We were allowed the freedom to take a very complex science concept and transform it into a visually compelling story of how this revolutionary cancer drug actually works.”
Hybrid took home a second platinum statue in the “Self Promotion/Demo Reel” category for their 2006 promotional reel. One gold Aurora went for an animation produced for Pfizer Global Pharmaceuticals, while the other was awarded for an awareness-building animation on the spread of avian flu.
The Aurora Awards is an independent competition designed to recognize excellence in the film and video industries. The Auroras specifically target non-national commercials, regional, or special interest entertainment and corporate-sponsored film and video. Judging is provided by a panel of film and video writers, producers, and directors; each of whom is a previous Aurora winner. Entries are received from across the US and abroad.
Epeius Biotechnologies Corporation is a privately held biopharmaceutical company dedicated to the advancement of genetic medicine with the development and commercialization of its proprietary targeted delivery systems. Credited with innovations ranging from oncogene discovery, to designer therapeutic genes, to pathotropic (disease-seeking) targeting, to high-performance vector engineering, to advanced biopharmaceutical manufacturing and bioprocess development, Epeius Biotechnologies is well positioned to launch its enabling platform technologies for the benefit of cancer patients worldwide.
Hybrid Medical Animation, Inc. produces cutting-edge 3D medical and scientific animation for the pharmaceutical, medical device, healthcare, and biotechnology industries. The Minneapolis-based studio employs ten full-time animators and a staff board-certified physician. Hybrid’s industry leading, scientifically accurate animations have been recognized by the Medical Marketing Association, and others, for excellence. 
Source: Hybrid Medical Animation
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
These articles might interest you as well: